Cargando…

Editorial: Developments in sickle cell disease therapy and potentials for gene therapy

Detalles Bibliográficos
Autores principales:	Maitta, Robert W., Reeves, Hollie M., Fontaine, Magali J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311059/ https://www.ncbi.nlm.nih.gov/pubmed/37396895 http://dx.doi.org/10.3389/fmed.2023.1208192

Ejemplares similares

Editorial: Thrombotic Microangiopathies, Diagnostic and Therapeutic Advances
por: Maitta, Robert W., et al.
Publicado: (2021)

Chronic red cell exchange in sickle cell patients with iron overload may not affect mortality
por: Zhou, Yi Yuan, et al.
Publicado: (2022)

Immature Platelet Dynamics in Immune-Mediated Thrombocytopenic States
por: Reeves, Hollie M., et al.
Publicado: (2020)

Development of curative therapies for sickle cell disease
por: Tanhehco, Yvette C., et al.
Publicado: (2022)

Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology
por: Mohanty, Dipika
Publicado: (2022)

Editorial: Global excellence in gene and cell therapy: Europe
por: Mendonça, Liliana, et al.
Publicado: (2023)

Editorial: Mechanism and therapy of autoimmune skin diseases
por: Mao, Xuming, et al.
Publicado: (2023)

Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2022)

Editorial: Modern Approaches to Hemophilia Management: Gene Therapy and Beyond
por: Coriu, Daniel, et al.
Publicado: (2022)

Editorial: Sickle cell disease.
por: Pearson, H. A.
Publicado: (1974)

Editorial: Advances in chronic kidney disease diagnosis and therapy
por: Ali, Hamad, et al.
Publicado: (2023)

Editorial: Nuclear medicine in rheumatological diseases' therapy and diagnosis
por: Treglia, Giorgio, et al.
Publicado: (2023)

Editorial: Personalized therapy in ARDS
por: Battaglini, Denise, et al.
Publicado: (2023)

Editorial: Music Therapy in Geriatrics
por: Hanser, Suzanne B., et al.
Publicado: (2020)

Potential Implications of a Type 1 Interferon Gene Signature on COVID-19 Severity and Chronic Inflammation in Sickle Cell Disease
por: Madany, Emaan, et al.
Publicado: (2021)

Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies
por: Lu, Lu, et al.
Publicado: (2019)

Editorial: ImmunoPET imaging in disease diagnosis and therapy assessment
por: Mulero, Francisca
Publicado: (2023)

Editorial: Physical therapy in the treatment of skin diseases and its mechanism
por: Hamblin, Michael R., et al.
Publicado: (2023)

Investigational curative gene therapy approaches to sickle cell disease
por: Williams, David A., et al.
Publicado: (2021)

Glomerular filtration rate abnormalities in sickle cell disease
por: Afangbedji, Nowah, et al.
Publicado: (2022)

Clonal hematopoiesis in sickle cell disease
por: Liggett, L. Alexander, et al.
Publicado: (2022)

Editorial: Profiling the tumour microenvironment to unveil biomarkers and develop novel therapeutics for cancer therapy
por: Jaillon, Sebastien, et al.
Publicado: (2023)

Editorial: Recent Developments in Therapies and Diagnostic Tools for Melanoma and Non-melanoma Skin Cancer
por: Fujimura, Taku, et al.
Publicado: (2020)

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
por: Poletti, Valentina, et al.
Publicado: (2018)

Editorial: Targeted alpha particle therapy in oncology
por: Bruland, Øyvind Sverre, et al.
Publicado: (2023)

The Role of Non-genetic Therapies to Reduce the Incidence of Sickle Cell Crisis: A Systematic Review
por: Pingili, Shravya, et al.
Publicado: (2023)

The APC-EPCR-PAR1 axis in sickle cell disease
por: Ramadas, Nirupama, et al.
Publicado: (2023)

A systems pharmacology model for gene therapy in sickle cell disease
por: Zheng, Bo, et al.
Publicado: (2021)

Editorial: Biomarkers in CKD
por: Araujo, Magali, et al.
Publicado: (2017)

Editorial: Modern Endovascular Therapy for Peripheral Arterial Disease
por: Loffroy, Romaric, et al.
Publicado: (2021)

Editorial: Exosomes in cardiovascular diseases: Mechanism, diagnosis, and therapy
por: Zhang, Xiao, et al.
Publicado: (2022)

Hypertransfusion Therapy in Sickle Cell Disease in Nigeria
por: Adewoyin, Ademola Samson, et al.
Publicado: (2014)

Drug Therapies for the Management of Sickle Cell Disease
por: Rai, Parul, et al.
Publicado: (2020)

Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
por: Germino-Watnick, Paula, et al.
Publicado: (2022)

Emerging disease-modifying therapies for sickle cell disease
por: Carden, Marcus A., et al.
Publicado: (2019)

Sickle Cell Disease and Its Respiratory Complications
por: Khan, Mashal I, et al.
Publicado: (2022)

Sickle Cell Disease: Thoughts for India From the Jamaican Cohort Study
por: Serjeant, Graham R.
Publicado: (2021)

Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease
por: Pavan, Aline Renata, et al.
Publicado: (2022)

Editorial: Antimicrobial resistance and therapy in critically ill patients
por: Li, Qi, et al.
Publicado: (2023)

Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches
por: Marcuzzi, Annalisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ce5qcvu5ir3j0ck41bk3e7p16i